5.80 -1.26 (-17.85%)

53.23% Fall from 52W High

2.1M XNAS Volume

High volume+loss today

XNAS 21 Mar, 2025 5:30 PM (EDT)

Monte Rosa Therapeutics Inc - GLUE - stock price prediction, stock price target, analyst ratings from 8 analysts

Monte Rosa Therapeutics Inc has a share price target of US$ 15, revenue growth forecast of -9.2%, for FY25, based on top 8 analyst calls.